The BSL3 in Rotterdam, was founded to accommodate safe research on infectious diseases, such as COVID-19. The BSL3 research lab facility in Rotterdam was designed to operate according to the highest international biosafety and biosecurity standards, and to facilitate research to multiple teams simultaneously, thus providing unique opportunities for collaborative COVID-19 research using a variety of research modalities including high end instruments for experiments and analyses, in vivo (animals) and in vitro.

Czech Centre for Phenogenomics (CCP) generates rodent models related to diagnosis, treatment and prevention of the Covid-19 virus infection (e.g. several serine protease mouse mutant lines). Available resources, services and support include generation of rodent disease models relevant for Covid-19 research, standard cryopreservation and archiving services, advanced secondary phenotyping pipelines relevant to lung inflammation and fibrosis, pre-clinical testing, metabolomics and MALDI imaging from tissue samples and biopsies. Project proposals can be submitted by email, and will be evaluated and conducted with the highest priority.

CCP is a member of INFRAFRONTIER and due to the comprehensive portfolio of its expertise, it has also become a member of international consortium IMPC. 

CIISB (Czech Infrastructure for Integrative Structural Biology) offers priority access to research groups, which need to use the CIISB structural biology services for R&D projects directly related to the studies of the SARS-CoV-2 virus and projects aiming to develop an effective vaccine and/or treatment of Covid-19 disease. To request the priority access, please submit the research proposal with "COVID-19" in the title through the online application system. Successfully accepted proposals will be free of charge, and no financial contribution will be requested for the measurement and provided services.

The Italian National Agency for New Technologies, Energy and Sustainable Economic Development (ENEA), in order to contribute to research on COVID-19, makes its high-performance computing infrastructure HPC CRESCO6 available - free-of-charge access - to the entire scientific community involved in research activities and application projects for the coronavirus emergency.

In response to the COVID-19 pandemic, the National Research Infrastructure for Biological and Medical Imaging (Czech-BioImaging), as the Czech national node to the Euro-BioImaging ERIC pan-European network, offers prioritised access to Czech-BioImaging facilities with no fees attached for COVID-19 relevant scientific projects, selected for implementation within the ongoing call for the Czech-BioImaging Open Access support (July 2020 – June 2021). Deadline for submitting applications is 30th April 2020. More information and the application rules can be found at Czech-BioImaging website. 

The Czech National Node to the European Clinical Research Infrastructure Network (CZECRIN) offers its support, services and expertise to all research-oriented physicians, with the aim of involving its forces in quick access to initiate national and especially transnational clinical trials. CZECRIN launched a dedicated website (available in Czech), to inform not only the professional, but also the non-expert public, about all ongoing and planned activities towards clinical research. Moreover, the NATIONAL CTUs NETWORK, a unit of CZECRIN, has been mapping the interest of healthcare facilities participating in the individual clinical trials focusing on the treatment of patients with the COVID-19 disease, which can be found on this website. In addition, the RI initiated the international study CZECRIN COVID-19, in collaboration with the Slovak SLOVACRIN network, aimed at evaluating the efficacy and safety of the combination of hydroxychloroquine and azithromycin in hospitalized patients with acute respiratory impairment requiring oxygen therapy. Furthermore, CZECRIN will offer research capacity and administrative support to other facilities to battle COVID-19.

In the light of the current events regarding the spread of new strain of coronavirus SARS-CoV-2 and Covid-19 disease, Czech e-infrastructure e-INFRA CZ offers priority access to resources and services for projects focused on mitigating the pandemic spread. For these purposes, e-INFRA CZ offers services and knowledge in the areas of remote collaboration, computation, data storage, and computer networking.

The Extreme Light Infrastructure (ELI Beamlines) offers rapid access to the experimental cluster for advanced ultrafast optical spectroscopy and X-ray diffraction, to support the investigation of the SARS-CoV-2 virus characteristics and the development of possible vaccine and treatments. More information about the ELI Beamlines scientific cluster can be found here. Proposals and experiments will be supported by Research Programme 4 for Applications in Molecular, Bio-medical and Material Science, jointly with the ELIBIO Project teams. More information on available support (bio and bio-chemical) labs is available here.

In coordination with the FabLabs of Wallonia, the FabLab Mons has been involved since the beginning of the epidemic in the development and production of solutions to fight Covid-19 and thus help healthcare professionals who are on the front line. More than 6,000 of protective visors have been produced to date and are intended for the medical professionals, firemen, policemen etc. The aim of these visors is to extend the life of the masks by avoiding projections. This project is possible with the help of volunteers and the support of UMONS, Fund for Medical Research in Hainaut (FRMH) and the FEDER.

GENCI,  the French HPC agency, is providing its HPC (high performance computing) and storage facilites (located into 3 national centers: TGCC for CEA, IDRIS for CNRS and CINES for French Universities), as well as the user support resources to researchers from academia and industry working on COVID-19. Such supercomputers are used to accelerate modelisation/simulation workloads, post-processing of massive amount of data and use at scale of artificial intelligence. Already 15 projects have been benefited from such fast track, in the fields of massive docking, development of vaccines and therapies, epidemiological research on the spread of the virus, and related applications.  

The GSI Helmholtzzentrum für Schwerionenforschung and the Facility for Antiproton and Ion Research (GSI/FAIR) develops innovative research strategies to support the fight against the current COVID-19 pandemic. The Biophysics Department plans to inactivate the virus with high-energy heavy ions in order to develop vaccines in cooperation with the Helmholtz Centre for Infection Research (HZI). In addition, the therapeutic effect of low-dose radiation against pneumonia caused by SARS-CoV-2 is currently being investigated. The Materials Research Department is working on membranes made of nanopores for improved and fast virus detection and for the development of tailored membranes for viral filtration masks.

The PCR-RT capabilities of the Romanian National Institute for Biological Sciences (INCDSB) - member of the ESFRI Consortium DANUBIUS-RI - as part of the global efforts to fight against COVID -19, has made available the services for the Coronavirus testing and is now very actively cooperating with the Romanian Government in the testing campaign at national level. INCDSB is actively supporting Romanian Government with trained personnel, logistics and infrastructure (several devices and a laboratory of cell cultures with expertise in cytotoxicity testing of medical devices).

IRTA-CReSA is a public research institute devoted to research in animal health following the One Health concept. In the context of COVID-19 crisis, the BSL3 large animal and laboratory facilities can support SARS-CoV-2 isolation, in vitro studies of anti-viral and antibody efficacy, in vivo studies of anti-viral, antibody and vaccine efficacy (once hACE2 transgenic mice become available),  antiviral, antibody and vaccine research, and animal infection model development.

IT4Innovations National Supercomputing Centre at VŠB – Technical University of Ostrava has offered its users from academic institutions priority access to its computational resources to solve problems regarding the Covid-19 disease research. Applicants focused on mitigating the coronavirus spread may submit the project proposals within the "Director’s Discretion scheme". Applications will be approved immediately and given significantly higher priority to use the IT4Innovations computational resources.

The hosting laboratory of the KM3NeT Infrastructure"Laboratori Nazionali del Sud" (LNS) of INFN, in collaboration with the University of Catania, has realized a laboratory for the verification of the functional qualities of fabrics intended for the manufacture of masks and other Personal Protective Equipment (PPE) for the prevention of contagion in the COVID-19 emergency. The ANTI_COVID-LAB laboratory will provide technical-scientific assistance to companies that may request to test fabrics to make masks and other medical  devices according to the standards set by current regulations, by performing the characterization of the materials, their morphological analysis and will study the capability of the tissues to prevent the virus diffusion.

LINDAT/CLARIAH-CZ and its host institution – the Institute of Formal and Applied Linguistics at the Faculty of Mathematics and Physics, Charles University, Prague – offers its computing cluster capacity for research computation devoted to fight the SARS-CoV-2 coronavirus and Covid-19 disease, in the amount of ~1000 CPUs, for the period of three months, starting 1st April 2020. More information on how to apply for an account and quota on the cluster, plus a technical description of the capabilities of the cluster, how to run jobs, transfer data etc., can be found here. Please note that decisions to allow access will be made at the discretion of the research infrastructure management and mainly on first-come first-serve basis if fulfilling the above criteria.

LINDAT/CLARIAH-CZ is a joint distributed Czech national node of the pan-European CLARIN ERIC (Common Language Resources and Technology Infrastructure) and DARIAH ERIC (Digital Research Infrastructure for the Arts and Humanities) networks.

The Leibniz Institute for Resilience Research (LIR) provides a wide range resources and information about how to psychologically deal with the COVID-19 pandemic and how to stay mentally healthy, and participates in number of relative research studies. Amongst them, the large multilingual study DynaCORE-C and its longitudinal arm DynaCORE-L, which examine the psychological responses to the COVID-19 pandemic using anonymous online surveys. Other related studies, available only in German, include LORA-COVID, COSMO-Panel, COVID-19-Intensiv, and the upcoming online-training study Auf Kurs Bleiben (Stay on track).

Researchers worldwide are trying to develop drugs or a vaccine against the coronavirus SARS-CoV-2. In view of the corona pandemic, the Heinz Maier-Leibnitz Zentrum (MLZ) offers special access to measurements with neutrons, which can provide important insights into the behaviour of the virus. Scientists who want to use neutrons to study the corona virus SARS-CoV-2 or the disease COVID-19 will have special and privileged access, and do not have to apply for measurement time through the usual channels. Guest scientists should contact the user office directly with their applications for measurement time. A scientific evaluation of the application will then take place as soon as possible.

The Open Data Infrastructure for Social Science and Economic Innovations Dutch (ODISSEI) brings together researchers with the necessary data, expertise and resources to conduct ground-breaking research and embrace the computational turn in social enquiry. In response to the COVID-19 pandemic, ODISSEI has granted two data proposals, by awarding time on the LISS data panel for corona-related research into home-schooling (Dr. Thijs Bol, University of Amsterdam) and the distribution of care responsibilities (Dr. Mara A. Yerkes, Utrecht University).

RECETOX RI supports the Government of Czechia in managing the pandemic outbreak of Covid-19 by analysing, interpreting and modelling the available population data needed for development of population-protecting strategies and IT tools. RECETOX RI is also fighting the pandemic outbreak of Covid-19 by the virtual screening. The in-house software tool CaverDock can be applied for virtual screening of potential drugs against protein targets identified in the context of coronavirus pandemic. CaverDock has been developed during the last four years and is publicly available via the website.

The SSH COVID-19 portal, the expert portal for Dutch Social Sciences and Humanities, aims to consolidate and organize the SSH expertise across the Dutch universities in a publicly available national portal, ensuring fast and direct access to academic experts.